Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240212450230/en/

Media contact:
[email protected]

Investor contact:
[email protected]

Source: Johnson & Johnson

You May Also Be Interested In

• Bouygues Telecom Becomes First Mobile Network Operator in France to Launch App-Free Nuisance Call Protection
• 80 practical tools to help leaders strengthen mathematics instruction
• NaaS Technology Inc.'s Parent Company Named to 2026 China Top 500 Private Enterprises List, Recognized for AI-Driven Energy Digitalization